Clinical Trials

A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Patients with Unresectable Stage III or Stage IV Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 07-156]
A Phase I Study of PLX4032 in Patients with Metastatic Melanoma
Chapman, Paul, MD

[Protocol 06-148]
A Phase II Study of Imatinib in Patients with Inoperable Stage III or IV Melanoma with Alterations in the C-KIT Protein
Carvajal, Richard, MD

[Protocol 07-014]
A Phase II Study of Nilotinib (AMN107) in Patients with Metastatic Mucosal, Acral, or Chronically Sun-Damaged Melanoma
Carvajal, Richard, MD

[Protocol 09-055]
A Phase II Trial of AZD6244 in Patients with V600E BRAF-Mutated Melanomas
Chapman, Paul, MD

[Protocol 09-003]
A Phase III Study of Ipilimumab versus Placebo after Complete Resection of High-Risk Stage III Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 08-085]
A Phase Ia/Ib Study of a DNA Vaccine in Patients with Stage IIB-IV Malignant Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 07-003]
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
Wolchok, Jedd, MD, PhD

[Protocol 09-012]
Genetic Variates of Response to Cisplatin/Vinblastine/Temozolomide Therapy in Patients with Metastatic Melanoma
Chapman, Paul, MD

[Protocol 09-017]
Health Communication in Families
Ostroff, Jamie, PhD

[Protocol 03-088]
Illness Related Distress in Women with Clinically Localized Cutaneous Melanoma
Brady, Mary, MD

[Protocol 08-096]
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
Oliveria, Susan, ScD, MPH

[Protocol 06-128]
Pilot Trial to Determine Toxicity and Antibody Responses with a Vaccine Containing GD2 Lactone and GD3 Lactone in Patients with Disease-Free Stage III or IV Melanoma
Chapman, Paul, MD

[Protocol 06-086]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org